• Interim US guidance for risk assessment and public health management of persons with potential 2019 novel coronavirus (2019-nCoV) exposure in travel-associated or community settings Cite CITE Title : Interim US guidance for risk assessment and public health management of persons with potential 2019 novel coronavirus (2019-nCoV) exposure in travel-associated or community settings Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : February 3, 2020 Series : 2019 novel coronavirus URL : https://stacks.cdc.gov/view/cdc/84776 File Format: Copy Export RIS [PDF - 691.22 KB] Corporate Authors: National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. February 3, 2020 | 2019 novel coronavirus Description: This interim guidance is effective as of February 3, 2020, and does not apply retrospectively to people who have been in China during the previous 14 ... File Type: [PDF - 691.22 KB] File Type: [PDF - 691.22 KB] 2019-nCoV situation summary 2019 novel coronavirus (2019-nCoV) in the U.S : updated February 3, 2020 Cite CITE Title : 2019-nCoV situation summary 2019 novel coronavirus (2019-nCoV) in the U.S : updated February 3, 2020 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : February 3, 2020 Series : 2019 novel coronavirus URL : https://stacks.cdc.gov/view/cdc/84778 File Format: Copy Export RIS [PDF - 258.21 KB] Corporate Authors: Centers for Disease Control and Prevention (U.S.) February 3, 2020 | 2019 novel coronavirus Description: This is an emerging, rapidly evolving situation and CDC will provide updated information as it becomes available, in addition to updated guidance.Upda... File Type: [PDF - 258.21 KB] File Type: [PDF - 258.21 KB] Transcript for CDC telebriefing : CDC update on novel coronavirus : press briefing transcript : Monday, February 3, 2020 Cite CITE Title : Transcript for CDC telebriefing : CDC update on novel coronavirus : press briefing transcript : Monday, February 3, 2020 Personal Author(s) : Messonnier, Nancy E. Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : February 3, 2020 Series : 2019 novel coronavirus URL : https://stacks.cdc.gov/view/cdc/84774 File Format: Copy Export RIS [PDF - 88.35 KB] Personal Author: Messonnier, Nancy E. February 3, 2020 | 2019 novel coronavirus Description: Please Note: This transcript is not edited and may contain errors. File Type: [PDF - 88.35 KB] File Type: [PDF - 88.35 KB] 2019 novel coronavirus frequently asked questions and answers Cite CITE Title : 2019 novel coronavirus frequently asked questions and answers Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : February 3, 2020 Series : 2019 novel coronavirus URL : https://stacks.cdc.gov/view/cdc/84775 File Format: Copy Export RIS [PDF - 73.52 KB] Corporate Authors: National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. February 3, 2020 | 2019 novel coronavirus No Description File Type: [PDF - 73.52 KB] File Type: [PDF - 73.52 KB] 2019 novel coronavirus : prevention & treatment Cite CITE Title : 2019 novel coronavirus : prevention & treatment Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : February 3, 2020 Series : 2019 novel coronavirus URL : https://stacks.cdc.gov/view/cdc/84771 File Format: Copy Export RIS [PDF - 45.70 KB] Corporate Authors: National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. February 3, 2020 | 2019 novel coronavirus No Description File Type: [PDF - 45.70 KB] File Type: [PDF - 45.70 KB]

More +